The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Parent entities and officers
Active
5
- 1
Webster, Mark Christopher
Vp International Operations born in December 1964Individual (3 offsprings)Officer
2019-09-13 ~ dissolvedOF - Director → CIF 0 - 2
Saltzman, Jamie
Vp Global Sales born in February 1968Individual (1 offspring)Officer 2019-09-13 ~ dissolvedOF - Director → CIF 0 - 3
Knell Moore, Richard
Regional Sales Director born in February 1976Individual (3 offsprings)Officer 2021-04-07 ~ dissolvedOF - Director → CIF 0 - 4
Toet, Dirk-jan
Director Of Sales Emea Pad born in May 1967Individual (1 offspring)Officer 2019-09-13 ~ dissolvedOF - Director → CIF 0 - 5
500, Burdick Pkwy, Deerfield, United StatesCorporate (1 offspring)Person with significant control 2016-04-06 ~ dissolvedPE - Ownership of voting rights - 75% or more → CIF 0PE - Ownership of shares – 75% or more → CIF 0
Ceased
12
- 1
Hildage, Roy Stuart Jnr
Director born in April 1963Individual (1 offspring)Officer 2003-05-29 ~ 2007-03-09OF - Director → CIF 0 - 2
Khemani, Ashwin
Ceo born in September 1975IndividualOfficer 2012-01-18 ~ 2015-10-13OF - Director → CIF 0 - 3
Ingram, Shaun
Medical Devices born in July 1971Individual (3 offsprings)Officer 2010-04-13 ~ 2021-04-06OF - Director → CIF 0Ingram, Shaun
Individual (3 offsprings)Officer 2015-07-01 ~ 2019-08-26OF - Secretary → CIF 0 - 4
De Greef, Roderick
Executive born in March 1961IndividualOfficer 2003-05-28 ~ 2005-10-31OF - Director → CIF 0De Greef, Roderick
ExecutiveIndividualOfficer 2003-05-28 ~ 2005-10-31OF - Secretary → CIF 0 - 5
Balasubramanian, Saravanan
Head Of R & D born in July 1969IndividualOfficer 2012-01-18 ~ 2015-10-13OF - Director → CIF 0 - 6
Forsey, John Declan
Medical Equipment born in July 1959IndividualOfficer 2007-03-12 ~ 2007-07-02OF - Director → CIF 0 - 7
Hinson, John
Executive born in July 1962IndividualOfficer 2007-10-31 ~ 2009-03-30OF - Director → CIF 0 - 8
Cohen, Raymond
Executive born in April 1959IndividualOfficer 2003-05-28 ~ 2007-10-31OF - Director → CIF 0 - 9
Matysik, Michael
Executive born in March 1959IndividualOfficer 2007-10-31 ~ 2011-01-14OF - Director → CIF 0 - 10
Lemvigh, Kurt
Executive born in April 1960IndividualOfficer 2003-05-28 ~ 2015-07-01OF - Director → CIF 0Lemvigh, Kurt
ExecutiveIndividualOfficer 2005-10-31 ~ 2015-07-01OF - Secretary → CIF 0 - 11
OVALSEC LIMITED
- nowOVALSHELFCO (NUMBER SIXTEEN) LIMITED - 1978-12-312 Temple Back East, Temple Quay, BristolActive Corporate (11 parents, 37 offsprings)Officer2003-05-18 ~ 2003-05-28PE - Nominee Secretary → CIF 0 - 12
OVAL NOMINEES LIMITED
- nowOVAL (179) LIMITED - 1984-12-102 Temple Back East, Temple Quay, BristolActive Corporate (11 parents, 8 offsprings)Officer2003-05-18 ~ 2003-05-28PE - Nominee Director → CIF 0
Company in focus
CARDIAC SCIENCE HOLDINGS (UK) LIMITED
Previous names
CARDIAC SCIENCE (U.K.) LIMITED - 2004-03-03
OVAL (1848) LIMITED - 2003-05-22
Standard Industrial Classification
47749 - Retail Sale Of Medical And Orthopaedic Goods In Specialised Stores (not Incl. Hearing Aids) N.e.c.
Brief company account
Par Value of Share
Class 1 ordinary share
12020-04-01 ~ 2021-03-31
Turnover/Revenue
5,847,180 GBP2020-04-01 ~ 2021-03-31
12,005,518 GBP2019-01-01 ~ 2020-03-31
Cost of Sales
4,386,256 GBP2020-04-01 ~ 2021-03-31
9,371,196 GBP2019-01-01 ~ 2020-03-31
Gross Profit/Loss
1,460,924 GBP2020-04-01 ~ 2021-03-31
2,634,322 GBP2019-01-01 ~ 2020-03-31
Administrative Expenses
1,099,622 GBP2020-04-01 ~ 2021-03-31
2,133,117 GBP2019-01-01 ~ 2020-03-31
Operating Profit/Loss
351,831 GBP2020-04-01 ~ 2021-03-31
501,205 GBP2019-01-01 ~ 2020-03-31
Other Interest Receivable/Similar Income (Finance Income)
596 GBP2020-04-01 ~ 2021-03-31
2,451 GBP2019-01-01 ~ 2020-03-31
Profit/Loss on Ordinary Activities Before Tax
-2,984,615 GBP2020-04-01 ~ 2021-03-31
503,656 GBP2019-01-01 ~ 2020-03-31
Tax/Tax Credit on Profit or Loss on Ordinary Activities
73,811 GBP2020-04-01 ~ 2021-03-31
97,474 GBP2019-01-01 ~ 2020-03-31
Profit/Loss
-3,058,426 GBP2020-04-01 ~ 2021-03-31
406,182 GBP2019-01-01 ~ 2020-03-31
Property, Plant & Equipment
16,873 GBP2020-03-31
Fixed Assets - Investments
81,481 GBP2020-03-31
Fixed Assets
98,354 GBP2020-03-31
Total Inventories
578,347 GBP2020-03-31
Debtors
221,603 GBP2021-03-31
5,376,435 GBP2020-03-31
Cash at bank and in hand
1,086,969 GBP2021-03-31
1,211,437 GBP2020-03-31
Current Assets
1,308,572 GBP2021-03-31
7,166,219 GBP2020-03-31
Creditors
Current
897,143 GBP2021-03-31
3,794,718 GBP2020-03-31
Net Current Assets/Liabilities
411,429 GBP2021-03-31
3,371,501 GBP2020-03-31
Total Assets Less Current Liabilities
411,429 GBP2021-03-31
3,469,855 GBP2020-03-31
Equity
Called up share capital
100 GBP2021-03-31
100 GBP2020-03-31
100 GBP2018-12-31
Retained earnings (accumulated losses)
411,329 GBP2021-03-31
3,469,755 GBP2020-03-31
3,063,573 GBP2018-12-31
Equity
411,429 GBP2021-03-31
3,469,855 GBP2020-03-31
3,063,673 GBP2018-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-3,058,426 GBP2020-04-01 ~ 2021-03-31
406,182 GBP2019-01-01 ~ 2020-03-31
Comprehensive Income/Expense
-3,058,426 GBP2020-04-01 ~ 2021-03-31
406,182 GBP2019-01-01 ~ 2020-03-31
Wages/Salaries
574,989 GBP2020-04-01 ~ 2021-03-31
1,394,408 GBP2019-01-01 ~ 2020-03-31
Social Security Costs
72,457 GBP2020-04-01 ~ 2021-03-31
174,117 GBP2019-01-01 ~ 2020-03-31
Staff Costs/Employee Benefits Expense
647,446 GBP2020-04-01 ~ 2021-03-31
1,568,525 GBP2019-01-01 ~ 2020-03-31
Average Number of Employees
102020-04-01 ~ 2021-03-31
192019-01-01 ~ 2020-03-31
Director Remuneration
176,645 GBP2020-04-01 ~ 2021-03-31
409,981 GBP2019-01-01 ~ 2020-03-31
Property, Plant & Equipment - Depreciation Expense
Owned assets
17,135 GBP2020-04-01 ~ 2021-03-31
5,886 GBP2019-01-01 ~ 2020-03-31
Audit Fees/Expenses
12,026 GBP2020-04-01 ~ 2021-03-31
15,000 GBP2019-01-01 ~ 2020-03-31
Current Tax for the Period
71,578 GBP2020-04-01 ~ 2021-03-31
97,240 GBP2019-01-01 ~ 2020-03-31
Tax Expense/Credit at Applicable Tax Rate
-567,077 GBP2020-04-01 ~ 2021-03-31
95,695 GBP2019-01-01 ~ 2020-03-31
Property, Plant & Equipment - Gross Cost
Improvements to leasehold property
37,671 GBP2021-03-31
37,671 GBP2020-03-31
Property, Plant & Equipment - Gross Cost
37,933 GBP2021-03-31
37,671 GBP2020-03-31
Furniture and fittings
262 GBP2021-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Improvements to leasehold property
37,671 GBP2021-03-31
20,798 GBP2020-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
37,933 GBP2021-03-31
20,798 GBP2020-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Improvements to leasehold property
16,873 GBP2020-04-01 ~ 2021-03-31
Furniture and fittings
262 GBP2020-04-01 ~ 2021-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
17,135 GBP2020-04-01 ~ 2021-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Furniture and fittings
262 GBP2021-03-31
Property, Plant & Equipment
Improvements to leasehold property
16,873 GBP2020-03-31
Investments in Group Undertakings
Cost valuation
81,481 GBP2020-03-31
Investments in Group Undertakings
81,481 GBP2020-03-31
Merchandise
578,347 GBP2020-03-31
Trade Debtors/Trade Receivables
Current
211,496 GBP2021-03-31
1,101,336 GBP2020-03-31
Amounts Owed by Group Undertakings
Current
4,146,161 GBP2020-03-31
Other Debtors
Current
87,392 GBP2020-03-31
Amount of value-added tax that is recoverable
Current
27,280 GBP2020-03-31
Debtors - Deferred Tax Asset
Current
2,233 GBP2020-03-31
Prepayments/Accrued Income
Current
10,107 GBP2021-03-31
12,033 GBP2020-03-31
Debtors
Amounts falling due within one year, Current
221,603 GBP2021-03-31
5,376,435 GBP2020-03-31
Trade Creditors/Trade Payables
Current
97,580 GBP2021-03-31
145,364 GBP2020-03-31
Amounts owed to group undertakings
Current
318,751 GBP2021-03-31
3,268,582 GBP2020-03-31
Corporation Tax Payable
Current
81,332 GBP2021-03-31
22,228 GBP2020-03-31
Other Taxation & Social Security Payable
Current
3,327 GBP2021-03-31
32,088 GBP2020-03-31
Other Creditors
Current
20,495 GBP2021-03-31
37,063 GBP2020-03-31
Accrued Liabilities
Current
364,461 GBP2021-03-31
289,393 GBP2020-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
43,232 GBP2021-03-31
43,232 GBP2020-03-31
Between one and five year
134,428 GBP2020-03-31
All periods
43,232 GBP2021-03-31
177,660 GBP2020-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2021-03-31
Profit/Loss
Retained earnings (accumulated losses)
-3,058,426 GBP2020-04-01 ~ 2021-03-31
CARDIAC SCIENCE HOLDINGS (UK) LIMITED
InfoCARDIAC SCIENCE (U.K.) LIMITED - 2004-03-03OVAL (1848) LIMITED - 2004-03-03Registered number 04768341Unit 9 Seymour Court, Runcorn WA7 1SYPRIVATE LIMITED COMPANY incorporated on 2003-05-18 and dissolved on 2022-09-13 (19 years 3 months). The company status is Dissolved.CIF 0
Offspring entities and appointments
Active
0
- Not found in our database.
The content of this website is protected by AgonGuard.
© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 12 November 2025 and
licensed under the Open Government Licence v3.0.